NIZO has a long track record of adding value to infant and clinical companies and improving production processes. We can often increase production yields by 5-15%. The global infant and clinical nutrition market is large and has shown considerable growth in recent years. Especially the infant nutrition business has grown enormously. The main drivers behind this growth are the increase in disposable income, especially in China, growing birth rates in Asia, Africa and the Middle East and the rising population of working women who are looking for user friendly products. In addition, other developments such as an increasing number of young children with specific needs, hypo-allergenic formulas, consumer migration towards premium quality offerings and the desire of companies to minimise their environmental footprint impact this growth. The growth drives companies in this industry to keep innovating, and the need to offer premium quality products with novel ingredients continues.

Our videos

Optimization of in vitro MicroColon technology

Optimization of in vitro MicroColon technology for maintaining a more representative infant fecal microbiota by Guus Kortman, Scientist and Senior Project Manager Microbiomics at NIZO: "Let’s meet at ILSI 2020 Europe e-Annual Symposium (6 October) where I show you how NIZO optimized the in vitro MicroColon model to better represent the infant gut microbiota, for reliable screening of newgut microbiota modulators."

Digestive and immune health benefits - Client statement FrieslandCampina

NIZO supports a healthy lifestyle by substantiating health benefits of food. In this video, Marjolijn Bragt of FrieslandCampina talks about her collaboration with @NIZO in an integrated approach to build a convincing case, in which the scientific and regulatory guidance, targeted preclinical studies, well-designed clinical trials, biomarker analysis and expert interpretation are combined.

 Regulatory requirements demand a sound scientific background for each new product to be launched in the market. In addition, infant and clinical companies continue to invest in efficient and effective processing in their factories to keep up with the global increase in demand, while minimising the environmental footprint. NIZO has a long track record of adding value to infant and clinical companies and improving production processes. We can often increase production yields by 5-15%. We also offer support in implementing novel ingredients in products by combining application knowledge with innovative product development techniques. We have helped many companies with efficient up-scaling in our food grade processing centre and supported clinical trials, especially in the microbiome field, to strengthen dossiers for presentation to regulatory bodies. To find out more, take a look at our brochures:

Any questions?

Ioana Iorga is happy to answer all your questions.

Meet Ioana Iorga